Vicarious Surgical to Report Third Quarter 2025 Financial Results on November 12, 2025 Share WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. ("Vicarious Surgical†or the "Company†) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced it will now report financial results for the third quarter ended September 30, 2025 after the market closes on Wednesday, November 12, 2025. Company management will host a corres ...

Intuitive Surgical on Tuesday reported better-than-expected third-quarter profit and revenue, driven by growing demand for its surgical robots used in minimally invasive procedures. ...

We recently published Wall Street Analysts Like These 10 Stocks. Johnson & Johnson (NYSE:JNJ) is one of the stocks analysts were recently talking about. Josh Brown, CEO of Ritholtz Wealth Management, explained in a latest program on CNBC why he likes Johnson & Johnson (NYSE:JNJ). Brown said the company’s upcoming quarterly report next month could be a big catalyst. “The general idea is that if and when a stock breaks out from a typical range that it’s been stuck in, in this case like 5 years, the move co ...

Group 1 - Medtronic has a historically high dividend yield of around 3% and is working on improving its business performance, which could make it a strong healthcare stock to consider [1] - The company has faced challenges due to a development dry spell but is now gaining traction with new surgical robots and cardiac ablation systems [2] - Medtronic is focusing on its most profitable businesses, with a significant move being the spinoff of its diabetes treatment division, which is expected to be immediately accretive to earnings [3] Group 2 - As new products are introduced, Medtronic's earnings growth may exceed Wall Street's expectations, driven by higher profit margins and increased revenues from R&D developments [4] - The current high yield provides an opportunity for investors to benefit while waiting for the market to recognize the improving fundamentals of Medtronic's business [4] - Medtronic's growth has stalled in recent years, but the company is actively bringing new products to market and focusing on its most profitable segments [6]